National Cancer Institute "Cancer Moonshot Biobank"
Recruiting
1,600 enrolled
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Recruiting
1,100 enrolled
MOMENTUM
Recruiting
8,000 enrolled
DP-04
Recruiting
100 enrolled
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
Recruiting
750 enrolled
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Recruiting
100 enrolled
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
Completed
64 enrolled
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recruiting
2,000 enrolled
iCaRe2
Recruiting
999,999 enrolled
CAMPERR
Recruiting
7,000 enrolled
CCANED-CIPHER
Recruiting
6,000 enrolled
Mobile Sensor Technologies to Assess General Symptomology of People With Cancer
Completed
49 enrolled
IMPLICATION
Completed
167 enrolled
Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots
Recruiting
200 enrolled
Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-Irradiation
Completed
149 enrolled
SBRT
Completed
98 enrolled
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
Recruiting
350 enrolled
PRIORITY
Completed
346 enrolled 9 charts
Tempus Priority Study: A Pan-tumor Observational Study
Active not recruiting
1,000 enrolled
SURVIMON
Active not recruiting
100,000 enrolled
A Clinical Evaluation of AI Solutions Developed in the CHAIMELEON Project for Cancer: Prostate, Lung, Breast, Colon and Rectum
Completed
300 enrolled
Eligibility Screening for the NIH Intramural Research Program Clinical Protocols
Completed
19,522 enrolled
PREFER
Completed
1,429 enrolled
INSPIRE
Recruiting
5,350 enrolled
MOHCCN-O
Recruiting
500 enrolled
Improving Evidence-Based Care for Cancer Patients
Completed
128 enrolled
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Withdrawn
The Impact of Radiotherapy on Oligometastatic Cancer
Recruiting
2,000 enrolled
QUANTUM
Enrolling by invitation
3,000 enrolled
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Completed
484 enrolled
CER
Recruiting
15,000 enrolled
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Recruiting
2,700 enrolled
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
Completed
2,310 enrolled
Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer
Completed
4,000 enrolled
GBCPRT0008
Withdrawn
Early Detection and Staging of Endobronchial Lung and Pleural Cancer, Airway Injury, and Prostate Cancer
Withdrawn
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Completed
5,133 enrolled
PASSION
Unknown
1,800 enrolled
SPACE2
Unknown
150 enrolled
Patient-Reported Outcome Measurement Information System (PROMIS) Physical Function
Completed
1 enrolled
A Pilot Study of [Ga-68]PSMA PET/MRI for the Assessment of PSMA-positive Tumors
Completed
8 enrolled
PIONEER
Unknown
1,000 enrolled
Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities
Completed
2,472 enrolled
NIRPA
Completed
27 enrolled
Influence of Psychosocial Distress and Lifetime Trauma Exposure on Traumatic Stress Among Oncology Patients on Clinical Trials
Completed
55 enrolled
Study to Evaluate the Safety of Nanoxel M Inj.
Unknown
1,498 enrolled
PREDICARE
Completed
420 enrolled
End of Life Treatment Preferences of Latino Medicare Beneficiaries With Cancer
Unknown
230 enrolled
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Completed
3,571 enrolled
E-MOSAIC Electronic Tool to Monitor Symptoms
Completed
264 enrolled